Results for tag: "Medulloblastoma Drug"

Medulloblastoma is a type of brain cancer that affects the cerebellum, the part of the brain responsible for movement and coordination. Treatment for medulloblastoma typically involves a combination of surgery, radiation therapy, and chemotherapy. Drug therapies for medulloblastoma are designed to target the cancer cells while minimizing damage to healthy cells. These drugs are typically administered orally or intravenously. The medulloblastoma drug market is a rapidly growing segment of the brain cancer drug market. Companies are developing new drugs to target the cancer cells more effectively and reduce the side effects of existing treatments. These drugs are designed to improve the quality of life for patients and increase their chances of survival. Some companies in the medulloblastoma drug market include Novartis, Pfizer, Merck, and Bristol-Myers Squibb. Show Less Read more